117 related articles for article (PubMed ID: 7217914)
21. The rabbi's dilemma. [Interview by Alison George].
Ekstein J
New Sci; 2004 Feb 14-20; 181(2434):44-7. PubMed ID: 15085821
[No Abstract] [Full Text] [Related]
22. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?
Zlotogora J; Leventhal A
Isr Med Assoc J; 2000 Sep; 2(9):665-7. PubMed ID: 11062764
[TBL] [Abstract][Full Text] [Related]
23. Tay-Sachs disease: Part 2. Model of a fatal, preventable, metabolic, genetic disorder.
Hecht F; Anatole P; Szucs SC
Ariz Med; 1984 Oct; 41(10):661-5. PubMed ID: 6508567
[No Abstract] [Full Text] [Related]
24. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.
Broide E; Zeigler M; Eckstein J; Bach G
Am J Med Genet; 1993 Aug; 47(2):213-5. PubMed ID: 8213907
[TBL] [Abstract][Full Text] [Related]
25. Tay-Sachs disease.
Gelbart M
Nurs Times; 1998 Mar 18-24; 94(11):39. PubMed ID: 9697531
[No Abstract] [Full Text] [Related]
26. Screening for reproductive counseling: social, ethical, and medicolegal issues in the Tay-Sachs disease experience.
Kaback MM
Prog Clin Biol Res; 1982; 103 Pt B():447-59. PubMed ID: 7163239
[No Abstract] [Full Text] [Related]
27. Perspectives on screening and prevention of Tay-Sachs disease in Israel.
Padeh B; Shacher S; Katznelson MB; Navon R; Goldman B
Prog Clin Biol Res; 1977; 18():47-53. PubMed ID: 601094
[No Abstract] [Full Text] [Related]
28. Pitfalls in Tay-Sachs carrier detection: physician referral patterns and patient ignorance.
Shapiro DA; Shapiro LR
N Y State J Med; 1989 Jun; 89(6):317-9. PubMed ID: 2739956
[TBL] [Abstract][Full Text] [Related]
29. The Tay-Sachs disease screening program in the U.S. as a model for the control of genetic disease: an historical view.
Edelson PJ
Health Matrix Clevel; 1997; 7(1):125-33. PubMed ID: 10167171
[No Abstract] [Full Text] [Related]
30. The control of genetic disease by carrier screening and antenatal diagnosis: social, ethical, and medicolegal issues.
Kaback MM
Birth Defects Orig Artic Ser; 1982; 18(7):243-54. PubMed ID: 7159734
[No Abstract] [Full Text] [Related]
31. Automated thermal fractionation of serum hexosaminidase: effects of alteration in reaction variables and implications for Tay-Sachs disease heterozygote screening.
Kaback MM; Bailin G; Hirsch P; Roy C
Prog Clin Biol Res; 1977; 18():197-212. PubMed ID: 23554
[No Abstract] [Full Text] [Related]
32. Tay-Sachs heterozygote screening: specificity and sensitivity.
Scriver CR; Gold RJ
Prog Clin Biol Res; 1977; 18():239-43. PubMed ID: 601079
[TBL] [Abstract][Full Text] [Related]
33. Confidential Tay-Sachs carrier screening.
Rosner F
N Y State J Med; 1989 Oct; 89(10):585. PubMed ID: 2608220
[No Abstract] [Full Text] [Related]
34. Human hexosaminidase isozymes. IV. Effects of oral contraceptive steroids on serum hexosaminidase activity.
Nitowsky HM; Davis J; Nakagawa S; Fox D
Am J Obstet Gynecol; 1979 Jul; 134(6):642-7. PubMed ID: 463955
[TBL] [Abstract][Full Text] [Related]
35. Screening for Tay-Sachs disease.
Int J Gynaecol Obstet; 1996 Mar; 52(3):311-2. PubMed ID: 8775693
[No Abstract] [Full Text] [Related]
36. Determinants of utilization of Tay-Sachs screening.
Garber AP; Platt LD; Wang SJ; Jam K; Carlson DE; Rotter JI
Obstet Gynecol; 1993 Sep; 82(3):460-3. PubMed ID: 8355954
[TBL] [Abstract][Full Text] [Related]
37. Tay-Sachs disease among Moroccan Jews.
Vecht J; Zeigler M; Segal M; Bach G
Isr J Med Sci; 1983 Jan; 19(1):67-9. PubMed ID: 6832951
[No Abstract] [Full Text] [Related]
38. Genetic screening and counseling.
Norton ME
Curr Opin Obstet Gynecol; 2008 Apr; 20(2):157-63. PubMed ID: 18388816
[TBL] [Abstract][Full Text] [Related]
39. Tay-Sachs disease in South Africa.
Kromberg JG
S Afr Med J; 1981 Mar; 59(14):476. PubMed ID: 7209729
[No Abstract] [Full Text] [Related]
40. Carrier parents of Tay Sachs disease and beta-thalassemia.
Shah B; Bhavsar R
Indian Pediatr; 2005 May; 42(5):498-9. PubMed ID: 15923705
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
